載入...
The assay design used for measurement of therapeutic antibody concentrations can affect pharmacokinetic parameters: Case studies
To interpret pharmacokinetic (PK) data of biotherapeutics, it is critical to understand which drug species is being measured by the PK assay. For therapeutic antibodies, it is generally accepted that “free” circulating antibodies are the pharmacologically active form needed to determine the PK/ phar...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Landes Bioscience
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3499303/ https://ncbi.nlm.nih.gov/pubmed/22820463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.20814 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|